Endoscopic submucosal dissection (ESD) represents a significant advance in therapeutic endoscopy with the major advantage being the ability to achieve a higher en bloc resection rate for early stage ...

Background and Aim: Gastrointestinal stromal tumors (GISTs), the most common mesenchymal tumors of the digestive tract with potential for malignant transformation, are mainly treated by open surgery ...

Incidence of brain metastases in HER2+ gastric or esogastric junction adenocarcinoma. This is an ASCO Meeting Abstract from the 2013 Gastrointestinal Cancers Symposium. This abstract does not include ...

Insights from a 21-year analysis of mortality due to hypertension and esophageal cancer in the United States. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does ...

Gastric lesions include benign, dysplastic, and malignant tumours. Patients may be asymptomatic or experience loss of appetite and weight, anaemia and abdominal discomfort or pain. The procedure is ...

Malignant or premalignant changes in the oesophagus may take the form of either squamous cell carcinoma or adenocarcinoma, or their respective premalignant (dysplastic) forms. In the UK, approximately ...

Doctors are using endoscopic submucosal dissection (ESD) to remove some early gastrointestinal tumors without making external cuts, a shift that can speed recovery and keep organs intact when cancers ...